Jubilant Pharmova Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,000.00 +4.65 (0.47%)Updated : 14 May 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 12,756.40 | 11,548.50 | 11,156.65 | 9,990.87 |
| Accumulated Depreciation Total | -1,787.60 | -1,997.20 | -1,517.58 | -1,240.10 |
| Cash Equivalents | 19.60 | 50.70 | 18.03 | 29.08 |
| Other Liabilities Total | 1,792.20 | 662.70 | 362.61 | 103.47 |
| Accrued Expenses | 321.20 | 265.90 | 228.72 | 248.18 |
| Long Term Debt | 2,150.30 | 3,167.10 | 3,110.36 | 2,464.24 |
| Common Stock Total | 15.80 | 15.90 | 15.93 | 15.93 |
| Other Equity Total | 916.40 | 853.10 | - | - |
| Other Current Assets Total | 83.70 | 256.50 | 27.66 | 12.63 |
| Prepaid Expenses | 105.00 | 91.00 | 89.98 | 83.35 |
| Total Assets | 12,756.40 | 11,548.50 | 11,156.65 | 9,990.87 |
| Current Portof LT Debt/ Capital Leases | 123.20 | 102.60 | 94.86 | 451.57 |
| Cash | 1,066.60 | 903.20 | 992.76 | 951.19 |
| Total Equity | 6,254.90 | 5,433.90 | 5,399.28 | 5,318.56 |
| Long Term Investments | 49.50 | 42.20 | 256.42 | 238.60 |
| Retained Earnings( Accumulated Deficit) | 5,322.70 | 4,565.00 | 5,383.37 | 5,302.64 |
| Total Common Shares Outstanding | 15.84 | 15.84 | 15.91 | 15.92 |
| Property/ Plant/ Equipment Total- Gross | 6,955.80 | 5,684.30 | 4,882.70 | 4,031.20 |
| Tangible Book Valueper Share Common Eq | 165.20 | 121.67 | 126.96 | 135.04 |
| Goodwill Net | 2,541.00 | 2,463.90 | 2,428.59 | 2,242.75 |
| Total Liabilities | 6,501.50 | 6,114.60 | 5,757.37 | 4,672.30 |
| Total Debt | 2,731.00 | 3,664.00 | 3,676.76 | 3,192.00 |
| Cashand Short Term Investments | 1,086.20 | 953.90 | 1,010.78 | 980.26 |
| Total Receivables Net | 1,153.70 | 1,270.90 | 1,212.48 | 1,146.86 |
| Notes Payable/ Short Term Debt | 219.00 | 196.50 | 258.26 | 64.00 |
| Deferred Income Tax | 172.20 | 210.80 | 306.21 | 302.97 |
| Accounts Receivable- Trade Net | 1,005.30 | 1,014.30 | 1,051.48 | 992.54 |
| Property/ Plant/ Equipment Total- Net | 5,168.20 | 3,687.10 | 3,365.12 | 2,791.10 |
| Minority Interest | -16.30 | -12.80 | -7.49 | -2.16 |
| Total Current Liabilities | 2,164.60 | 1,889.00 | 1,772.40 | 1,591.60 |
| Total Inventory | 1,148.60 | 1,303.80 | 1,421.50 | 1,286.08 |
| Accounts Payable | 1,004.80 | 856.30 | 821.32 | 567.74 |
| Other Currentliabilities Total | 496.40 | 467.70 | 369.25 | 260.11 |
| Total Long Term Debt | 2,388.80 | 3,364.90 | 3,323.64 | 2,676.44 |
| Intangibles Net | 1,096.70 | 1,043.30 | 951.04 | 926.32 |
| Other Long Term Assets Total | 286.70 | 260.40 | 246.72 | 180.26 |
| Note Receivable- Long Term | 37.10 | 175.50 | 146.36 | 102.64 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 3,577.20 | 3,876.10 | 3,762.40 | 3,509.19 |
| Capital Lease Obligations | 238.50 | 197.80 | 213.28 | 212.19 |
| Treasury Stock- Common | - | -0.10 | -0.02 | -0.01 |
| Additional Paid- In Capital | - | - | 0.00 | 0.00 |
*All figures in crores except per share values
Jubilant Pharmova Quick Links
Jubilant Pharmova Dividend Jubilant Pharmova Bonus Jubilant Pharmova News Jubilant Pharmova AGM Jubilant Pharmova Rights Jubilant Pharmova Splits Jubilant Pharmova Board Meetings Jubilant Pharmova Key Metrics Jubilant Pharmova Shareholdings Jubilant Pharmova Profit Loss Jubilant Pharmova Cashflow Jubilant Pharmova Q1 Results Jubilant Pharmova Q2 Results Jubilant Pharmova Q3 Results Jubilant Pharmova Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
4,513.40+204.90(4.76%)
2,600.00+70.55(2.79%)
1,760.30+27.45(1.58%)
1,019.55-72.25 (-6.62%)
954.60-17.95 (-1.85%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.